413 related articles for article (PubMed ID: 26055920)
1. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
Xu Y; Zhou X; Suehs BT; Hartzema AG; Kahn MG; Moride Y; Sauer BC; Liu Q; Moll K; Pasquale MK; Nair VP; Bate A
Drug Saf; 2015 Aug; 38(8):749-65. PubMed ID: 26055920
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.
Zhou X; Murugesan S; Bhullar H; Liu Q; Cai B; Wentworth C; Bate A
Drug Saf; 2013 Feb; 36(2):119-34. PubMed ID: 23329543
[TBL] [Abstract][Full Text] [Related]
3. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership.
FitzHenry F; Resnic FS; Robbins SL; Denton J; Nookala L; Meeker D; Ohno-Machado L; Matheny ME
Appl Clin Inform; 2015; 6(3):536-47. PubMed ID: 26448797
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China.
Yang Y; Zhou X; Gao S; Lin H; Xie Y; Feng Y; Huang K; Zhan S
Drug Saf; 2018 Jan; 41(1):125-137. PubMed ID: 28815480
[TBL] [Abstract][Full Text] [Related]
5. Common Models, Different Approaches.
Gagne JJ
Drug Saf; 2015 Aug; 38(8):683-6. PubMed ID: 26088718
[No Abstract] [Full Text] [Related]
6. Transforming French Electronic Health Records into the Observational Medical Outcome Partnership's Common Data Model: A Feasibility Study.
Lamer A; Depas N; Doutreligne M; Parrot A; Verloop D; Defebvre MM; Ficheur G; Chazard E; Beuscart JB
Appl Clin Inform; 2020 Jan; 11(1):13-22. PubMed ID: 31914471
[TBL] [Abstract][Full Text] [Related]
7. Uptake of new drugs in the early post-approval period in the Mini-Sentinel distributed database.
Mott K; Graham DJ; Toh S; Gagne JJ; Levenson M; Ma Y; Reichman ME
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1023-32. PubMed ID: 27146123
[TBL] [Abstract][Full Text] [Related]
8. Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in Children.
Candore G; Hedenmalm K; Slattery J; Cave A; Kurz X; Arlett P
Clin Pharmacol Ther; 2020 Apr; 107(4):915-925. PubMed ID: 31956997
[TBL] [Abstract][Full Text] [Related]
9. Common Data Models (CDMs) to Enhance International Big Data Analytics: A Diabetes Use Case to Compare Three CDMs.
Liyanage H; Liaw ST; Jonnagaddala J; Hinton W; de Lusignan S
Stud Health Technol Inform; 2018; 255():60-64. PubMed ID: 30306907
[TBL] [Abstract][Full Text] [Related]
10. Design considerations, architecture, and use of the Mini-Sentinel distributed data system.
Curtis LH; Weiner MG; Boudreau DM; Cooper WO; Daniel GW; Nair VP; Raebel MA; Beaulieu NU; Rosofsky R; Woodworth TS; Brown JS
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():23-31. PubMed ID: 22262590
[TBL] [Abstract][Full Text] [Related]
11. Developing an ETL tool for converting the PCORnet CDM into the OMOP CDM to facilitate the COVID-19 data integration.
Yu Y; Zong N; Wen A; Liu S; Stone DJ; Knaack D; Chamberlain AM; Pfaff E; Gabriel D; Chute CG; Shah N; Jiang G
J Biomed Inform; 2022 Mar; 127():104002. PubMed ID: 35077901
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of OMOP CDM, i2b2 and ICGC ARGO for supporting data harmonization in a breast cancer use case of a multicentric European AI project.
Frid S; Bracons Cucó G; Gil Rojas J; López-Rueda A; Pastor Duran X; Martínez-Sáez O; Lozano-Rubí R
J Biomed Inform; 2023 Nov; 147():104505. PubMed ID: 37774908
[TBL] [Abstract][Full Text] [Related]
13. Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases.
Biedermann P; Ong R; Davydov A; Orlova A; Solovyev P; Sun H; Wetherill G; Brand M; Didden EM
BMC Med Res Methodol; 2021 Nov; 21(1):238. PubMed ID: 34727871
[TBL] [Abstract][Full Text] [Related]
14. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.
Platt R; Carnahan RM; Brown JS; Chrischilles E; Curtis LH; Hennessy S; Nelson JC; Racoosin JA; Robb M; Schneeweiss S; Toh S; Weiner MG
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():1-8. PubMed ID: 22262586
[TBL] [Abstract][Full Text] [Related]
15. The OMOP common data model in Australian primary care data: Building a quality research ready harmonised dataset.
Ward R; Hallinan CM; Ormiston-Smith D; Chidgey C; Boyle D
PLoS One; 2024; 19(4):e0301557. PubMed ID: 38635655
[TBL] [Abstract][Full Text] [Related]
16. Transforming Anesthesia Data Into the Observational Medical Outcomes Partnership Common Data Model: Development and Usability Study.
Lamer A; Abou-Arab O; Bourgeois A; Parrot A; Popoff B; Beuscart JB; Tavernier B; Moussa MD
J Med Internet Res; 2021 Oct; 23(10):e29259. PubMed ID: 34714250
[TBL] [Abstract][Full Text] [Related]
17. Conversion of CPRD AURUM Data into the OMOP Common Data Model.
Mayer CS
Inform Med Unlocked; 2023; 43():. PubMed ID: 38046363
[TBL] [Abstract][Full Text] [Related]
18. Exploring the potential of OMOP common data model for process mining in healthcare.
Park K; Cho M; Song M; Yoo S; Baek H; Kim S; Kim K
PLoS One; 2023; 18(1):e0279641. PubMed ID: 36595527
[TBL] [Abstract][Full Text] [Related]
19. [Benefits of large healthcare databases for drug risk research].
Garbe E; Pigeot I
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Aug; 58(8):829-837. PubMed ID: 26092163
[TBL] [Abstract][Full Text] [Related]
20. Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).
Hauben M; Aronson JK; Ferner RE
Drug Saf; 2016 May; 39(5):421-32. PubMed ID: 26879560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
